NCT05195827View on ClinicalTrials.gov

Effect of PRM-125 on Ambulatory Blood Pressure

PHASE3WithdrawnINTERVENTIONAL

0

Timeline

Start Date

December 20, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

November 30, 2022

Conditions

Hypertension

Interventions

DRUG

PRM-125

Antihypertensive

Trial Locations (1)

33134

AMR, Coral Gables

Sponsors

Lead Sponsor

PRM Pharma, LLC

All Listed Sponsors

lead

PRM Pharma, LLC

INDUSTRY